மாநாடு ஆன் தடுப்பூசி ஆராய்ச்சி News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from மாநாடு ஆன் தடுப்பூசி ஆராய்ச்சி. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In மாநாடு ஆன் தடுப்பூசி ஆராய்ச்சி Today - Breaking & Trending Today

Soligenix Announces Recent Accomplishments And First Quarter 2021 Financial Results

Soligenix Announces Recent Accomplishments And First Quarter 2021 Financial Results
News provided by
Share this article
Share this article
PRINCETON, N.J., May 17, 2021 /PRNewswire/ Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today its recent accomplishments and financial results for the quarter ended March 31, 2021.
This year continues to be an exciting year of progress for Soligenix, stated Christopher J. Schaber, PhD, President and Chief Executive Officer of Soligenix. We recently announced presentation of clinical data from our successful pivotal Phase 3 FLASH (Fluorescent Light Activated Synthetic Hypericin) clinical trial for HyBryte™ (SGX301) in the treatment of cutaneous T-cell lymphoma (CTCL) at both the American Academy of Dermatology, where HyBryte™ was designated To ....

United States , United Kingdom , Hellen Kim , Christopherj Schaber , Oreola Donini , Us Congress , National Institute Of Allergy , American Academy Of Dermatology Association Virtual Meeting , American Academy Of Dermatology , Soligenix Inc , Hospital Of The University Pennsylvania , Defense Threat Reduction Agency , Conference On Vaccinology Research , Prnewswire Soligenix Inc , Biomedical Advanced Research , Drug Administration , Society For Investigative Dermatology , Development Authority , Exchange Commission , Perelman Center , Public Health Solutions , Our Public Health Solutions , Chief Executive Officer , Fluorescent Light Activated Synthetic Hypericin , American Academy , Innovative Licensing ,

Dynavax Technologies (DVAX) Q1 2021 Earnings Call Transcript

Operator
Good day, ladies and gentlemen, and welcome to the Dynavax Technologies first-quarter 2021 conference call. As a reminder, this conference call is being recorded. At the end of the company s prepared remarks, we will open the call for questions and provide specific instructions at that point. I would now like to turn the call over to Nicole Arndt, senior manager, investor relations.
You may begin.
Senior Manager, Investor Relations
Thank you, operator. Good afternoon. Welcome to the Dynavax first-quarter 2021 financial results and corporate update conference call. Joining me on the call today are Ryan Spencer, chief executive officer; Kelly MacDonald, chief financial officer; Robert Janssen, chief medical officer; and Donn Casale, senior vice president, commercial. ....

United States , Josh Schimmer , Ryan Spencer , Kelly Macdonaldsure , Kelly Macdonald , Josh Schimmer Evercore , Nicole Arndt , Fernie Rodriguez , Donn Casale , Matt Phipps , Ernie Rodriguez Cowen , Robert Janssen , Matt Phipps William Blair , Phil Nadeau , William Blair , Conference On Vaccinology Research , Coalition For Epidemic Preparedness Initiative , European Commission , Advisory Committee On Immunization Practices , Company Analyst , Dynavax Technologies , Risk Factors , Immunization Practices , Vice President , Epidemic Preparedness Initiative , Clover Biopharmaceuticals ,

Soligenix Presents at the National Foundation for Infectious Diseases Annual Conference on Vaccinology Research

/PRNewswire/ Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing. ....

Oreola Donini , Axel Lehrer , Us Congress , University Of Hawai , Company Public Health Solutions , Conference On Vaccinology Research , National Foundation For Infectious Diseases , Biomedical Advanced Research , National Institute Of Allergy , National Institutes Of Health , Development Authority , Exchange Commission , Department Of Tropical Medicine , Soligenix Inc , Our Public Health Solutions , Defense Threat Reduction Agency , Senior Vice President , Chief Scientific Officer , Annual Conference , Vaccinology Research , Nano Emulsion Adjuvant The , Data Highlights , National Institutes , National Foundation , Infectious Diseases , Public Health Solutions ,

Two HEPLISAV-B Abstracts Selected for Oral Presentation at the 2021 Annual Conference on Vaccinology Research (ACVR)

Two HEPLISAV-B Abstracts Selected for Oral Presentation at the 2021 Annual Conference on Vaccinology Research (ACVR)
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

Derek Cole , Nicole Arndt , Conference On Vaccinology Research , National Foundation For Infectious Diseases , Kaiser Permanente Southern California Center , Dynavax Technologies Corporation Nasdaq , Conference For Vaccinology Research , Us Centers For Disease Control , European Union , Investor Relations Advisory Solutions , Dynavax Technologies Corporation , Vaccinology Research , Single Arm Study Evaluating , Hepatitisb Vaccine , Adults Receiving , Kaiser Permanente Southern California , Vaccine Safety , Annual Conference , National Foundation , Infectious Diseases , Disease Control , Toll Like Receptor , Senior Manager , டெரெக் கோல் , நிக்கோல் அரண்டட் , மாநாடு ஆன் தடுப்பூசி ஆராய்ச்சி ,

Two HEPLISAV-B Abstracts Selected for Oral Presentation at the 2021 Annual Conference on Vaccinology Research (ACVR)

Two HEPLISAV-B Abstracts Selected for Oral Presentation at the 2021 Annual Conference on Vaccinology Research (ACVR)
apnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from apnews.com Daily Mail and Mail on Sunday newspapers.

Derek Cole , Nicole Arndt , Conference On Vaccinology Research , National Foundation For Infectious Diseases , Kaiser Permanente Southern California Center , Conference For Vaccinology Research , Us Centers For Disease Control , Prnewswire Dynavax Technologies Corporation Nasdaq , European Union , Investor Relations Advisory Solutions , Technologies Corporation , Vaccinology Research , Single Arm Study Evaluating , Hepatitisb Vaccine , Adults Receiving , Kaiser Permanente Southern California , Vaccine Safety , Annual Conference , National Foundation , Infectious Diseases , Disease Control , Toll Like Receptor , Senior Manager , Investor Relations , டெரெக் கோல் , நிக்கோல் அரண்டட் ,